<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39411982</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2532-5264</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>16</Day></PubDate></JournalIssue><Title>Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace</Title><ISOAbbreviation>Monaldi Arch Chest Dis</ISOAbbreviation></Journal><ArticleTitle>Fibrotic outcomes from SARS-CoV-2 virus interstitial pneumonia.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.4081/monaldi.2024.3028</ELocationID><Abstract><AbstractText>Following the onset of the new COVID-19 pandemic, particular attention is paid to the long-term outcomes, especially concerning patients affected by the SARS-CoV-2 virus leading to interstitial pneumonia. The aim of this research is to evaluate the possible evolution over time of interstitial pneumonia into post-inflammatory fibrosing interstitial disease. This research included 42 patients admitted to the COVID ward for SARS-CoV-2 interstitial pneumonia, 10 patients with mild pneumonia and respiratory failure who were treated with O2 only, 32 patients with severe pneumonia in which O2 and non-invasive ventilation were used for respiratory assistance, and 4 patients treated with invasive mechanical ventilation. At 70Â±30 days, 6, 12, 24, and 36 months after discharge, the cohort of patients carried out the evaluation of inflammation indices, high-resolution computed tomography (CT) chest scans, and functional respiratory tests. The comparative analysis showed that 83.3% of patients had residual parenchymal lung disease at 36-month follow-up, with a significantly higher rate in those with severe pneumonia and more extensive disease on initial CT. Regarding the pulmonary involvement model, patients presented ground-glass opacity or peripheral parenchymal bands, or a combination of them, peri- and intralobular interstitial thickening, which may be representative of fibrotic interstitial lung disease. There is a correlation between the severity of pneumonia, the inflammatory state, the need to increase respiratory support, and the quantity and persistence of CT-related lesions. Reductions in respiratory functions and exercise capacity were observed, the latter more pronounced in patients (24%) who had contracted severe pneumonia and required ventilatory support.Pulmonary outcomes from SARS-CoV-2 respiratory infections show a wide range of radiological findings, from complete recovery to stable outcomes of thickening and distortion of the interstitial architecture. From a functional point of view, there is an impairment of the alveolar-capillary diffusion capacity and, in cases who had contracted severe pneumonia, desaturation and reduced exercise tolerance in 24% of cases at a 36-month follow-up.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Respiratory Physiopathology and Bronchial Endoscopy Unit, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA). luigi.pinto@miulli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schino</LastName><ForeName>Pietro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Respiratory Physiopathology and Bronchial Endoscopy Unit, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA). luigi.pinto@miulli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bitetto</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory Physiopathology and Bronchial Endoscopy Unit, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA). luigi.pinto@miulli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tedeschi</LastName><ForeName>Ersilia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Respiratory Physiopathology and Bronchial Endoscopy Unit, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA). luigi.pinto@miulli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maiellari</LastName><ForeName>Michele</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Respiratory Physiopathology and Bronchial Endoscopy Unit, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA). luigi.pinto@miulli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Leo</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Respiratory Physiopathology and Bronchial Endoscopy Unit, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA). luigi.pinto@miulli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ludovico</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Radiology Unit, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA). luigi.pinto@miulli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larizza</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Unit of Internal Medicine, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA). luigi.pinto@miulli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastroianni</LastName><ForeName>Franco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Unit of Internal Medicine, Ecclesiastical Entity General Regional Hospital 'F. Miulli', Acquaviva Delle Fonti (BA). luigi.pinto@miulli.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Monaldi Arch Chest Dis</MedlineTA><NlmUniqueID>9307314</NlmUniqueID><ISSNLinking>1122-0643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39411982</ArticleId><ArticleId IdType="doi">10.4081/monaldi.2024.3028</ArticleId></ArticleIdList></PubmedData></PubmedArticle>